Pulmonary hypertension in patients with heart failure with preserved ejection fraction: a literature review
Abstract
Pulmonary hypertension (PH) in the context of heart failure with preserved ejection fraction (HFpEF) is a prevalent and prognostically adverse condition. This review examines the epidemiology, pathogenesis, and subtypes of PH, as well as key biomarkers and hemodynamic parameters that influence prognosis. Key biomarkers and diagnostic thresholds are discussed alongside recent classification updates. The review emphasizes diagnostic challenges, especially distinguishing PH-HFpEF from pulmonary arterial hypertension. The review emphasizes the importance of early identification and a personalized approach to patients with PH-HFpEF.
Fields of Study & Subjects
Pulmonary Hypertension Research and Treatments
Heart Failure Treatment and Management
Cardiovascular Function and Risk Factors
Publication details
- Journal / source
- Russian Journal of Cardiology
- Volume
- 30
- Issue
- 2S
- Pages
- 6457–6457
- Publication date
- 26 January 2026